SenoRx Inc. (SENO) Not Liable For Patent Infringement
December 24, 2009 12:03 PM
SenoRx Inc. (NASDAQ: SENO) has been found not liable for patent infringement against Hologic Inc. (NASDAQ: HOLX), according to a report by Leerink Swann.
SenoRx Inc. (NASDAQ: SENO) has been found not liable for patent infringement against Hologic Inc. (NASDAQ: HOLX), according to a report by Leerink Swann.
Analysts at Leerink Swann believe that the verdict will have a small negative impact on the Hologic Inc. stock. Hologic Inc. had charged SenoRx Inc. of infringement of Hologic’s 6,413,204 and 6,482,142 patents. SenoRx had claimed that both patents were invalid and that the patent 204 was not infringed.The jury's verdict stated that SenoRx Inc. was not liable for the infringement of patent 204 and deemed both patents invalid.







